CD4 and neoplasm: This finding also supports the possibility that SBRT increases CD8+ T cell accumulation in tumor sites because the therapeutic efficacy of local ablative radiation critically depends on the presence of effector CD8+ T cells, but not CD4+ T cells (25–27).